Dr Michelle Miller, BSc, MSc, PhD GCertAppFin (Finsia)
Chief Executive Officer and Managing Director
Dr Miller has worked for over 25 years in the bioscience industry, with extensive experience in commercial drug development. She completed her PhD in the Faculty of Medicine at Sydney University investigating molecular models of cancer development. Her experience includes several years at Johnson and Johnson developing anti-HIV gene therapeutics through preclinical research to clinical trials. She has finance industry experience from time spent as an Investment Manager with a specialist bioscience venture capital fund.
Dr Miller was appointed as Managing Director on 21 June 2002.
Mr Peter J. Nightingale
Company Secretary
Mr Nightingale graduated with a Bachelor of Economics degree from the University of Sydney and is a member of the Chartered Accountants Australia and New Zealand. He has worked as a chartered accountant in both Australia and the USA.
As a director or company secretary Mr Nightingale has, for more than 35 years, been responsible for the financial control, administration, secretarial and in-house legal functions of a number of private and public listed companies in Australia and the USA including Bolnisi Gold N.L. and Nickel Industries Limited.
Mr Nightingale is currently a director of ASX listed companies Alpha HPA Limited and Prospech Limited and unlisted public company Fulcrum Lithium Ltd.
Mr Nightingale has been Company Secretary since 23 February 1999.
